Publication Date: 18-04-2023
The pandemic has shown us what we are capable of when we work together across sectors and when innovation is on the side of humanity. Just over three years after the COVID-19 pandemic was declared, the world is resuming its daily activities, which are the engine of social development and economic growth. This is thanks to the efforts of the innovative biopharmaceutical industry, in collaboration with governments around the world and the international health authorities.
During the pandemic, innovation, scaling manufacturing, a socially responsible approach to pricing and sharing technology changed the course of the pandemic in record time.
But, despite the efforts of the global health community, equitable access to COVID-19 tools in the most vulnerable in low- and middle-income countries (LMICs) was compromised. Together with global stakeholders, the pharmaceutical industry is determined to accelerate equitable access to such life-saving tools now and for future global pandemics.
Sigue leyendo aquí